The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 22, 2015

Filed:

Oct. 29, 2010
Applicants:

T. G. Murali Dhar, Newtown, PA (US);

Hai-yun Xiao, Belle Mead, NJ (US);

Scott Hunter Watterson, Pennington, NJ (US);

Soo S. Ko, Hockessin, DE (US);

Alaric J. Dyckman, Lawrenceville, NJ (US);

Charles M. Langevine, Brooklyn, NY (US);

Jagabandhu Das, Mercerville, NJ (US);

Robert J. Cherney, Newtown, PA (US);

Inventors:

T. G. Murali Dhar, Newtown, PA (US);

Hai-Yun Xiao, Belle Mead, NJ (US);

Scott Hunter Watterson, Pennington, NJ (US);

Soo S. Ko, Hockessin, DE (US);

Alaric J. Dyckman, Lawrenceville, NJ (US);

Charles M. Langevine, Brooklyn, NY (US);

Jagabandhu Das, Mercerville, NJ (US);

Robert J. Cherney, Newtown, PA (US);

Assignee:

Bristol-Myers Squibb Company, Princeton, NJ (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 413/04 (2006.01); C07D 231/54 (2006.01); C07D 261/20 (2006.01); C07D 277/84 (2006.01); C07D 403/06 (2006.01); C07D 413/06 (2006.01); C07D 413/14 (2006.01); C07D 417/04 (2006.01); C07D 417/14 (2006.01); C07D 419/04 (2006.01); C07D 487/10 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
C07D 413/04 (2013.01); C07D 231/54 (2013.01); C07D 261/20 (2013.01); C07D 277/84 (2013.01); C07D 403/06 (2013.01); C07D 413/06 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 419/04 (2013.01); C07D 487/10 (2013.01); C07D 498/04 (2013.01);
Abstract

Disclosed are compounds of Formula (I) or stereoisomers or salts thereof, wherein: X, X, X, W, Q, Q, and Gare defined herein. Also disclosed are methods of using such compounds as selective agonists for G protein-coupled receptor S1P, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.


Find Patent Forward Citations

Loading…